 Please help me provide a clear and concise summary with the description in English below: 
<b>Study ID: </b>NCT04906330<br><b>Study Title: </b>Onco-liq: Kit for Breast Ca                                                    ncer Diagnosis.<br><b>Study Summary: </b>Onco-liq is a novel diagnosis kit for e                                                    arly breast cancer detection in blood based in liquid biopsies and microRNAs. Th                                                    is innovative kit will allow improving the accuracy of cancer diagnosis which wi                                                    ll impact on health, reducing the patient mortality and health costs.To develop                                                     this kit, it has been finished the preclinical PHASE I: in laboratory animals; P                                                    HASE II: exploratory clinical phase for the discovery of candidate biomarkers in                                                     breast cancer patients and PHASE III: clinical validation of biomarkers showing                                                     that Onco-liq has 95% specificity.Currently it is been setting up a "pilot test                                                    " for breast cancer to enrol 500 woman volunteers without previous cancer diagno                                                    sis that go to the annual medical control. The results of the pilot test will gi                                                    ve the accuracy for breast cancer early diagnosis and the management of Onco-liq                                                     positive patients.<br><b>Study Type: </b>Observational<br><b>Study EligibilityC                                                    riteria:<br></b>  <b>Inclusion Criteria:</b><br>    *Women patients performing g                                                    ynecological control<br>    *Between 50-70 years old<br>    *Without personal hi                                                    story of oncological disease<br>    *Informed consent signed<br>  <b>Exclusion C                                                    riteria:</b><br>    *Patients who don´t meet the inclusion criteria.<br>    *Act                                                    ive infection with SARS-CoV-2 (COVID-19).<br><b>Study Population: </b>Female pat                                                    ients, without a personal history of oncological pathology, who attend for gynec             